Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 482,500
-26,500 (-5.21%)
Last updated: Aug 31, 2026, 1:54 PM KST
Hanmi Pharm. Company Description
A globally active pharmaceutical company, Hanmi Pharm.
Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Hanmi Pharm. Co., Ltd.
| Country | South Korea |
| Founded | 1973 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jae-Hyun Park |
Contact Details
Address: 214 Muha-ro Hwaseong-si South Korea | |
| Phone | 82 3 1350 5600 |
Stock Details
| Ticker Symbol | 128940 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7128940004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae-Hyun Park | Chief Executive Officer and Director |
| Lim Chong-Yoon | President of Business Development and Executive Director |
| Jong-Hoon Lim | CSR Executive Director |
| Byung-hwa Shim | Chief Finance Officer |
| Yang-Hwan Choi | Group Head of IR |
| Jong-Soo Woo Ph.D. | Executive Director |
| Jong-Hoon Lim | Executive Director and Management Planning /CIO |
| Chang-Ju Choi | Vice President of Information Management Team |